Banu Atalar

• ASCO Resource Stratified Guidelines Committee (2013-2018),

• Chair of Young Turkish Society for Radiation Oncology (TROD) (2021-2023)

• Organizer of the National Congress of Turkish Society for Radiation Oncology (2023)

• Turkish Society for Radiation Oncology

Board Member 2021-2023

President-Elect and Vice President 2023- 2025

President, March 2025 - March 2027

• Radiosurgery Society (RSS) Scientific Meeting Organization Committee (2023, 2024, 2025)

• The RSS Nomination Committee (2024)

• ESTRO Chair of National Societies Committee, (2024-2027)

1. MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases.

Ugurluer G, Dincer N, Mustafayev TZ, Gungor G, Abacioglu MU, Sengoz M, Ozyar E, Atalar B.

Strahlenther Onkol. 2025 Jun;201(6):637-644. doi: 10.1007/s00066-024-02328-1. Epub 2024 Dec 2.

PMID: 39622976

 

2. Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study.

Sayan M, Eren AA, Tuac Y, Langoe A, Alali B, Aynaci O, Mohammadipour S, Vahedi F, Daneshmand B, Abbas W, Hawsawi Y, Nader T, Joseph J, Wahby R, Ozgenc I, Mula-Hussain L, Moningi S, Orio PF, Atalar B, Eren MF.

JCO Glob Oncol. 2024 Jul;10:e2400171. doi: 10.1200/GO.24.00171.

PMID: 38991182

 

3. Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.

Sayan M, Eren MF, Gupta A, Ohri N, Kotek A, Babalioglu I, Oskeroglu Kaplan S, Duran O, Derinalp Or O, Cukurcayir F, Kurtul N, Ceylaner Bicakci B, Kutuk T, Senyurek S, Turk A, Jabbour SK, Atalar B.

Adv Respir Med. 2019;87(5):289-297. doi: 10.5603/ARM.2019.0051.

PMID: 31680229 Free PMC article. Review.

 

4. What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach.

Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR 4th, Atalar B, Lieberson RE, Soltys SG.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):688-93. doi: 10.1016/j.ijrobp.2012.01.028. Epub 2012 Mar 22.

PMID: 22445007

 

5. Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.

Keskin S, Küçücük S, Ak N, Atalar B, Sarı M, Sozen H, Ibis K, Topuz S, Saip P.

Oncol Res Treat. 2019;42(3):101-106. doi: 10.1159/000494334. Epub 2019 Jan 19.

PMID: 30661076

 

6. Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: no good survival due to radiation pneumonitis.

Dinçbas FO, Atalar B, Koca S.

Lung Cancer. 2004 Feb;43(2):241-2. doi: 10.1016/j.lungcan.2003.08.022.

PMID: 14739045 No abstract available.

 

7. Adult langerhans cell histiocytosis of bones : a rare cancer network study.

Atalar B, Miller RC, Dincbas FO, Geismar JH, Micke O, Akyurek S, Ozyar E.

Acta Orthop Belg. 2010 Oct;76(5):663-8.

PMID: 21138223

 

8. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency (Int J Radiat Oncol Biol Phys 2011;79:660-669).

Atalar B, Caglar H, Ozyar E.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):521; author reply 521. doi: 10.1016/j.ijrobp.2011.06.1989.

PMID: 22244280 No abstract available.

 

9. Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer.

Atalar B, Aydin G, Gungor G, Caglar H, Yapici B, Ozyar E.

Technol Cancer Res Treat. 2012 Jun;11(3):249-55. doi: 10.7785/tcrt.2012.500293. Epub 2012 Mar 15.

PMID: 22417057 Free article.

 

10. In regard to Zhou et al "Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365).

Ozyar E, Caglar HB, Atalar B.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):482-3. doi: 10.1016/j.ijrobp.2012.01.052.

PMID: 22579373 No abstract available.

 

11. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer.

Atalar B, Gungor G, Caglar H, Aydin G, Yapici B, Ozyar E.

Tumori. 2012 May-Jun;98(3):331-6. doi: 10.1177/030089161209800309.

PMID: 22825509

 

12. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma.

Atalar B, Ozyar E, Gunduz K, Gungor G.

Radiol Oncol. 2010 Sep;44(3):194-8. doi: 10.2478/v10019-010-0013-0. Epub 2010 Sep 9.

PMID: 22933915 Free PMC article.

 

13. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module.

Gunn GB, Atalar B, Mendoza TR, Cleeland CS, Selek U, Özyar E, Rosenthal DI.

Balkan Med J. 2016 May;33(3):339-43. doi: 10.5152/balkanmedj.2015.150148. Epub 2016 May 1.

PMID: 27308079 Free PMC article.

 

14. Robotic radiosurgery of head and neck paragangliomas: a single institution experience.

Tosun İ, Atalar B, Şahin B, Güngör G, Aydin G, Yapici B, Özyar E.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e3-e7. doi: 10.1111/ajco.12695. Epub 2017 May 24.

PMID: 28544809

 

15. Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy.

Güngör G, Demir M, Aydın G, Yapıcı B, Atalar B, Özyar E.

J Appl Clin Med Phys. 2018 Jan;19(1):184-193. doi: 10.1002/acm2.12237. Epub 2017 Dec 7.

PMID: 29218841 Free PMC article.

 

16. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.

Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.

Radiother Oncol. 2018 Apr;127(1):96-102. doi: 10.1016/j.radonc.2017.12.028. Epub 2018 Jan 17.

PMID: 29373196

 

17. Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report.

Sahin B, Mustafayev T, Aydin G, Gungor G, Yapici B, Atalar B, Ozyar E.

Cureus. 2017 Dec 29;9(12):e2003. doi: 10.7759/cureus.2003.

PMID: 29507851 Free PMC article.

 

18. Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy : TROD 09-001 multi-institutional study.

Ozyigit G, Onal C, Igdem S, Alicikus ZA, Iribas A, Akin M, Yalman D, Cetin I, Aksu MG, Atalar B, Dincbas F, Hurmuz P, Guler OC, Aydin B, Sert F, Yildirim C, Gorken IB, Agaoglu FY, Korcum AF, Yuce D, Ozkok S, Darendeliler E, Akyol F.

Strahlenther Onkol. 2019 Oct;195(10):882-893. doi: 10.1007/s00066-019-01476-z. Epub 2019 May 29.

PMID: 31143994 English.

 

19. Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.

Durmaz EÖ, Atalar B, Sezer E, Özyar E, Çetin ED.

J Dtsch Dermatol Ges. 2019 Aug;17(8):832-833. doi: 10.1111/ddg.13888. Epub 2019 Jul 15.

PMID: 31305003 No abstract available.

 

20. Strahlentherapie bei Brustkrebs löst kutanen Lupus erythematodes aus.

Öztürk Durmaz E, Atalar B, Sezer E, Özyar E, Dikicioǧlu Çetin E.

J Dtsch Dermatol Ges. 2019 Aug;17(8):832-833. doi: 10.1111/ddg.13888_g.

PMID: 31437379 German. No abstract available.

 

21. Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases.

Sayan M, Zoto Mustafayev T, Sahin B, Kefelioglu ESS, Wang SJ, Kurup V, Balmuk A, Gungor G, Ohri N, Weiner J, Ozyar E, Atalar B.

Radiat Oncol J. 2019 Dec;37(4):265-270. doi: 10.3857/roj.2019.00409. Epub 2019 Dec 31.

PMID: 31918464 Free PMC article.

 

22. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.

Asoglu O, Tokmak H, Bakir B, Demir G, Ozyar E, Atalar B, Goksel S, Koza B, Guven Mert A, Demir A, Guven K.

Eur J Surg Oncol. 2020 Mar;46(3):402-409. doi: 10.1016/j.ejso.2019.07.012. Epub 2019 Jul 8.

PMID: 31955995

 

23. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.

Sahin B, Zoto Mustafayev T, Gungor G, Aydin G, Yapici B, Atalar B, Ozyar E.

Cureus. 2019 Dec 24;11(12):e6457. doi: 10.7759/cureus.6457.

PMID: 32025388 Free PMC article.

 

24. Multichannel Film Dosimetry for Quality Assurance of Intensity Modulated Radiotherapy Treatment Plans Under 0.35 T Magnetic Field.

Gungor G, Korkmaz L, Kayalilar N Sr, Aydin G, Yapici B, Zoto Mustafayev T, Atalar B, Ozyar E.

Cureus. 2020 Mar 20;12(3):e7334. doi: 10.7759/cureus.7334.

PMID: 32313775 Free PMC article.

 

25. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors.

Atalar B, Mustafayev TZ, Sio TT, Sahin B, Gungor G, Aydın G, Yapici B, Ozyar E.

Radiol Oncol. 2020 Jun 26;54(4):480-487. doi: 10.2478/raon-2020-0039.

PMID: 32589607 Free PMC article.

 

26. Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002).

Hurmuz P, Onal C, Ozyigit G, Igdem S, Atalar B, Sayan H, Akgun Z, Kurt M, Ozkok HB, Selek U, Oymak E, Tilki B, Guler OC, Mustafayev TZ, Saricanbaz I, Rzazade R, Akyol F.

Strahlenther Onkol. 2020 Nov;196(11):1034-1043. doi: 10.1007/s00066-020-01660-6. Epub 2020 Jul 2.

PMID: 32617620

 

27. Time Analysis of Online Adaptive Magnetic Resonance-Guided Radiation Therapy Workflow According to Anatomical Sites.

Güngör G, Serbez İ, Temur B, Gür G, Kayalılar N, Mustafayev TZ, Korkmaz L, Aydın G, Yapıcı B, Atalar B, Özyar E.

Pract Radiat Oncol. 2021 Jan-Feb;11(1):e11-e21. doi: 10.1016/j.prro.2020.07.003. Epub 2020 Jul 30.

PMID: 32739438

 

28. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.

Sahin B, Atalar B, Kaytan Saglam E, Akgun Z, Abacioglu U, Arifoglu A, Ozyar E, Yaprak G, Ozseker Isik N, Guney Y, Caglar HB, Karaman S, Igdem S, Selek U, Berber T, Oner Dincbas F, Sengoz M, Yucel S, Demiral AN, Akyurek S.

Clin Respir J. 2020 Nov;14(11):1050-1059. doi: 10.1111/crj.13240. Epub 2020 Aug 17.

PMID: 32749053

 

29. Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].

Asoglu O, Tokmak H, Bakir B, Demir G, Ozyar E, Atalar B, Goksel S, Koza B, Mert AG, Demir A, Guven K.

Eur J Surg Oncol. 2020 Sep;46(9):1774. doi: 10.1016/j.ejso.2020.07.042.

PMID: 32800281 No abstract available.

 

30. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response.

Sayan M, Mustafayev TZ, Balmuk A, Mamidanna S, Kefelioglu ESS, Gungor G, Chundury A, Ohri N, Karaarslan E, Ozyar E, Atalar B.

Radiat Oncol J. 2020 Sep;38(3):176-180. doi: 10.3857/roj.2020.00171. Epub 2020 Jul 14.

PMID: 33012145 Free PMC article.

 

31. Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.

Sayan M, Serbez I, Teymur B, Gur G, Zoto Mustafayev T, Gungor G, Atalar B, Ozyar E.

Front Oncol. 2020 Sep 21;10:1782. doi: 10.3389/fonc.2020.01782. eCollection 2020.

PMID: 33072560 Free PMC article.

 

32. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.

Sayan M, Şahin B, Mustafayev TZ, Kefelioğlu EŞS, Vergalasova I, Gupta A, Balmuk A, Güngör G, Ohri N, Weiner J, Karaarslan E, Özyar E, Atalar B.

Neurocirugia (Engl Ed). 2020 Oct 17:S1130-1473(20)30111-1. doi: 10.1016/j.neucir.2020.08.009. Online ahead of print.

PMID: 33082103 English, Spanish.

 

33. Magnetic Resonance-Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report.

Sayan M, Mustafayev TZ, Atalar B, Gungor G, Ozyar E.

Adv Radiat Oncol. 2020 Mar 10;5(5):1066-1070. doi: 10.1016/j.adro.2020.02.009. eCollection 2020 Sep-Oct.

PMID: 33083668 Free PMC article. No abstract available.

 

34. Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.

Ugurluer G, Atalar B, Zoto Mustafayev T, Gungor G, Aydin G, Sengoz M, Abacioglu U, Tuna MB, Kural AR, Ozyar E.

Br J Radiol. 2021 Jan 1;94(1117):20200696. doi: 10.1259/bjr.20200696. Epub 2020 Oct 29.

PMID: 33095670 Free PMC article.

 

35. Magnetic resonance image-guided stereotactic body radiation therapy for liver rhabdoid tumor in infancy: A case report.

Egriboyun S, Ugurluer G, Corapcioglu FV, Celik L, Gungor G, Atalar B, Ozyar E.

J Med Imaging Radiat Sci. 2021 Jun;52(2):305-311. doi: 10.1016/j.jmir.2021.02.006. Epub 2021 Mar 16.

PMID: 33741278

 

36. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience.

Ugurluer G, Mustafayev TZ, Gungor G, Atalar B, Abacioglu U, Sengoz M, Agaoglu F, Demir G, Ozyar E.

Radiat Oncol J. 2021 Mar;39(1):33-40. doi: 10.3857/roj.2020.00976. Epub 2021 Mar 26.

PMID: 33794572 Free PMC article.

 

37. Magnetic resonance image-guided hypofractionated ablative radiation therapy for extrahepatic cholangiocarcinoma: Plan adaptation in changing anatomy.

Egriboyun S, Ugurluer G, Gungor G, Zoto Mustafayev T, Cicek B, Demir G, Atalar B, Ozyar E.

Med Dosim. 2021 Winter;46(4):435-439. doi: 10.1016/j.meddos.2021.06.001. Epub 2021 Jul 7.

PMID: 34244041

 

38. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.

Sayan M, Şahin B, Mustafayev TZ, Kefelioğlu EŞS, Vergalasova I, Gupta A, Balmuk A, Güngör G, Ohri N, Weiner J, Karaarslan E, Özyar E, Atalar B.

Neurocirugia (Engl Ed). 2021 Nov-Dec;32(6):261-267. doi: 10.1016/j.neucie.2020.08.007.

PMID: 34743823

 

39. Watch and Wait Strategy for Rectal Cancer: How Long Should We Wait for a Clinical Complete Response?

Asoglu O, Goksoy B, Aliyev V, Mustafayev TZ, Atalar B, Bakir B, Guven K, Demir G, Goksel S.

Surg Technol Int. 2022 May 19;40:130-139. doi: 10.52198/22.STI.40.CR1507.

PMID: 35090178

 

40. Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium.

Dincer N, Ugurluer G, Zoto Mustafayev T, Gungor G, Atalar B, Guven K, Ozyar E.

Cureus. 2022 Apr 9;14(4):e23981. doi: 10.7759/cureus.23981. eCollection 2022 Apr.

PMID: 35541296 Free PMC article.

 

41. Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports.

Dincer N, Ugurluer G, Korkmaz L, Serkizyan A, Atalar B, Gungor G, Ozyar E.

Cureus. 2022 Apr 9;14(4):e23980. doi: 10.7759/cureus.23980. eCollection 2022 Apr.

PMID: 35541303 Free PMC article.

 

42. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.

Bicakci BC, Mustafayev TZ, Cetinayak O, Igdem S, Birgi SD, Meydan D, Demircioglu F, Atalar B, Ozyar E, Akman F.

Head Neck. 2022 Aug;44(8):1825-1832. doi: 10.1002/hed.27101. Epub 2022 May 21.

PMID: 35596585

 

43. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases.

Kutuk T, Herrera R, Mustafayev TZ, Gungor G, Ugurluer G, Atalar B, Kotecha R, Hall MD, Rubens M, Mittauer KE, Contreras JA, McCulloch J, Kalman NS, Alvarez D, Romaguera T, Gutierrez AN, Garcia J, Kaiser A, Mehta MP, Ozyar E, Chuong MD.

Adv Radiat Oncol. 2022 Apr 25;7(6):100978. doi: 10.1016/j.adro.2022.100978. eCollection 2022 Nov-Dec.

PMID: 35647412 Free PMC article.

 

44. Magnetic Resonance Imaging-Guided Radiation Therapy for Early-Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.

Dincer N, Ugurluer G, Gungor G, Zoto Mustafayev T, Atalar B, Ozyar E.

Cureus. 2022 Sep 11;14(9):e29035. doi: 10.7759/cureus.29035. eCollection 2022 Sep.

PMID: 36249646 Free PMC article.

 

45. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.

Dincer N, Ugurluer G, Mustafayev TZ, Serkizyan A, Aydin G, Güngör G, Yapici B, Atalar B, Özyar E.

Brachytherapy. 2024 Jan-Feb;23(1):18-24. doi: 10.1016/j.brachy.2023.09.007. Epub 2023 Nov 23.

PMID: 38000958

 

46. Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome.

Ugurluer G, Zoto Mustafayev T, Gungor G, Abacioglu U, Atalar B, Ozyar E.

Clin Oncol (R Coll Radiol). 2024 Jan;36(1):12-20. doi: 10.1016/j.clon.2023.11.036. Epub 2023 Nov 22.

PMID: 38016848

 

47. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases.

Ugurluer G, Schneiders FL, Corradini S, Boldrini L, Kotecha R, Kelly P, Portelance L, Camilleri P, Ben-David MA, Poiset S, Marschner SN, Panza G, Kutuk T, Palacios MA, Castelluccia A, Zoto Mustafayev T, Atalar B, Senan S, Ozyar E.

Clin Transl Radiat Oncol. 2024 Feb 29;46:100756. doi: 10.1016/j.ctro.2024.100756. eCollection 2024 May.

PMID: 38450219 Free PMC article.

 

48. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review.

Atahan C, Ugurluer G, Kumbasar B, Ozyar E, Atalar B.

Cancer Radiother. 2024 Jun;28(3):275-279. doi: 10.1016/j.canrad.2023.10.001. Epub 2024 Jun 17.

PMID: 38890033 Review.

 

49. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy.

Zoto Mustafayev T, Turna M, Bolukbasi Y, Tezcanli E, Guney Y, Dincbas FO, Atasoy BM, Ugurluer G, Caglar HB, Atalar B, Ozyar E.

BMC Cancer. 2024 Jul 30;24(1):918. doi: 10.1186/s12885-024-12643-6.

PMID: 39080602 Free PMC article.

 

50. Multi-institutional analysis of extracranial oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: TROD 02-008 study.

Guler OC, Hurmuz P, Atalar B, Guney Y, Saglam EK, Akyurek S, Bolukbasi Y, Gural Z, Tugrul F, Korcum A, Sen CA, Yildirim BA, Oksuz DC, Kurt M, Guzeloz Z, Aksu G, Saynak M, Aksu G, Onal C.

Strahlenther Onkol. 2024 Nov;200(11):958-966. doi: 10.1007/s00066-024-02291-x. Epub 2024 Aug 19.

PMID: 39158748

 

51. Initial experience with MR-guided adaptive spinal stereotactic radiotherapy: a new indication for the MR-linac.

Dincer N, Zoto Mustafayev T, Atahan C, Gungor G, Ugurluer G, Abacioglu MU, Ozyar E, Atalar B.

Strahlenther Onkol. 2025 Dec;201(12):1289-1295. doi: 10.1007/s00066-025-02401-3. Epub 2025 Apr 28.

PMID: 40295375 Free PMC article.

 

52. Too Big to Burn? Just Beam It!

Atalar B, Dincer N.

Int J Radiat Oncol Biol Phys. 2025 Nov 15;123(4):921. doi: 10.1016/j.ijrobp.2025.06.3879.

PMID: 41101872 No abstract available.

 

53. Outcomes and PSA kinetics after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy (MRgSBRT) for prostate cancer.

Atahan C, Ugurluer G, Gungor G, Dincer N, Celebi E, Gul A, Atalar B, Sengoz M, Abacioglu U, Riza Kural A, Ozyar E.

Strahlenther Onkol. 2026 Feb 2. doi: 10.1007/s00066-026-02507-2. Online ahead of print.

PMID: 41627393

 

54. The rare cancer network: ongoing studies and future strategy.

Ozsahin M, Mirimanoff RO, Thariat J, Sun XS, Atalar B, Lassen-Ramshad Y, Ugurluer G, Krishnan S, Hallemeier C, Houtte PV, Krengli M, Zhang LJ, Chang K, Funk R, Rooney J, Miller RC.

Rare Tumors. 2014 Aug 8;6(3):5465. doi: 10.4081/rt.2014.5465. eCollection 2014 Jul 30.

PMID: 25276326 Free PMC article.

 

55. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ.

Turk J Gastroenterol. 2019 Jul;30(7):584-598. doi: 10.5152/tjg.2018.18737.

PMID: 30541724 Free PMC article. Review.

 

56. Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.

Onal C, Ozyigit G, Akgun Z, Atalar B, Igdem S, Oymak E, Agaoglu F, Selek U, Guler OC, Hurmuz P, Mustafayev TZ, Akyol F.

Clin Nucl Med. 2021 Jun 1;46(6):465-470. doi: 10.1097/RLU.0000000000003558.

PMID: 33661210

 

57. Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes - Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004).

Elmali A, Akkus Yildirim B, Cengiz M, Yuce Sari S, Onal HC, Berber T, Arslantas Erken A, Zoto Mustafayev T, Atalar B, Unal I, Kaydihan N, Oner Dincbas F.

Oncol Res Treat. 2022;45(12):717-727. doi: 10.1159/000527052. Epub 2022 Sep 16.

PMID: 36116432 Free article.

 

58. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.

Atalar B, Modlin LA, Choi CY, Adler JR, Gibbs IC, Chang SD, Harsh GR 4th, Li G, Nagpal S, Hanlon A, Soltys SG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):713-8. doi: 10.1016/j.ijrobp.2013.07.034. Epub 2013 Sep 18.

PMID: 24054875

 

59. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery.

Atalar B, Choi CY, Harsh GR 4th, Chang SD, Gibbs IC, Adler JR, Soltys SG.

Neurosurgery. 2013 Feb;72(2):180-5; discussion 185. doi: 10.1227/NEU.0b013e31827b99f3.

PMID: 23149969

 

60. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.

Hiniker SM, Modlin LA, Choi CY, Atalar B, Seiger K, Binkley MS, Harris JP, Liao YJ, Fischbein N, Wang L, Ho A, Lo A, Chang SD, Harsh GR, Gibbs IC, Hancock SL, Li G, Adler JR, Soltys SG.

Semin Radiat Oncol. 2016 Apr;26(2):97-104. doi: 10.1016/j.semradonc.2015.11.008. Epub 2015 Dec 4.

PMID: 27000505 Review.

 

61. LONG-TERM RESULTS OF EXTREMITY SOFT TISSUE SARCOMAS LIMB-SPARING SURGERY AND RADIOTHERAPY.

Dogan ÖY, Oksuz DÇ, Atalar B, Dincbas FO.

Acta Ortop Bras. 2019 Jul-Aug;27(4):207-211. doi: 10.1590/1413-785220192704217574.

PMID: 31452621 Free PMC article.

 

62. Postoperative radiotherapy in the treatment of uterine sarcomas: long-term results and analysis of prognostic factors.

Sahinler I, Atalar B, Tecer GM, Calay Z, Koca S, Atkovar G, Okkan S.

J BUON. 2010 Jul-Sep;15(3):480-8.

PMID: 20941814

 

63. Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study.

Ergen ŞA, Dinçbaş FÖ, Metcalfe E, Gül ŞK, Akyürek S, Yavaş G, Özdemir BŞ, Yücel B, Altınok A, Atalar B, Altınok P, Yakar M, Tepetam H, Birgi SD, Yavaş Ç, Korcum AF, Tatlı AM, Yumuk F.

Clin Transl Oncol. 2026 Apr;28(4):1234-1245. doi: 10.1007/s12094-025-04092-9. Epub 2025 Oct 24.

PMID: 41134441

 

64. The impact of malnutrition in the radiotherapy pathway in geriatric patients in the onco-surgical settings on behalf of the Turkish Society for Radiation Oncology Study Group (TROD 12-04).

Yurut-Caloglu V, Serarslan A, Kanyilmaz G, Saglam EK, Hurmuz P, Oksuz DC, Dincbas FO, Yalman D, Kocak Z, Atalar B, Demircan V, Kilic N, Caloglu M, Sürsal A.

Eur J Surg Oncol. 2025 Aug;51(8):110057. doi: 10.1016/j.ejso.2025.110057. Epub 2025 Apr 15.

PMID: 40318414

 

65. Determining Residents' Concerns About Staying Up to Date: Turkish Society for Radiation Oncology-Young Radiation Oncologists' Cross-Sectional National Survey (TROD/GROG 007).

Yilmaz MT, Kahvecioglu A, Gultekin M, Atalar B, Ozyigit G, Selek U.

JCO Glob Oncol. 2025 Apr;11:e2400589. doi: 10.1200/GO-24-00589. Epub 2025 Apr 28.

PMID: 40294365

 

66. Impact of Prolonged Neoadjuvant Treatment-surgery Interval on Histopathologic and Operative Outcomes in Patients Undergoing Total Mesorectal Excision for Locally Advanced Rectal Cancer.

Akbaba AC, Zenger S, Aytac E, Yozgatli TK, Bengür FB, Esen E, Bilgin IA, Sahin B, Atalar B, Sezen D, Erdamar S, Kapran Y, Ozben V, Baca B, Balik E, Hamzaoglu I, Bugra D, Karahasanoglu T.

Surg Laparosc Endosc Percutan Tech. 2020 Dec;30(6):511-517. doi: 10.1097/SLE.0000000000000836.

PMID: 32694403

 

67. Access to Radiation Therapy by Syrian Refugees Displaced to Turkey.

Dagoglu N, Karaman S, Atalar B, Miller RC, Oral EN.

Adv Radiat Oncol. 2022 Jul 15;7(4):100976. doi: 10.1016/j.adro.2022.100976. eCollection 2022 Jul-Aug.

PMID: 35865370 Free PMC article.

 

68. What have we gained by performing robotic rectal resection? Evaluation of 64 consecutive patients who underwent laparoscopic or robotic low anterior resection for rectal adenocarcinoma.

Erguner I, Aytac E, Boler DE, Atalar B, Baca B, Karahasanoglu T, Hamzaoglu I, Uras C.

Surg Laparosc Endosc Percutan Tech. 2013 Jun;23(3):316-9. doi: 10.1097/SLE.0b013e31828e3697.

PMID: 23752000

 

69. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging.

Gultekin M, Guler OC, Yuce Sari S, Akkus Yildirim B, Onal C, Celik H, Yuce K, Ayhan A, Arik Z, Kose F, Altundag O, Zoto Mustafayev T, Atalar B, Bolukbasi Y, Yildiz F.

J Obstet Gynaecol. 2021 Apr;41(3):414-420. doi: 10.1080/01443615.2020.1737661. Epub 2020 Apr 29.

PMID: 32347768

 

70. General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity.

Gul SK, Tepetam H, Yavuz BB, Gursel OK, Altinok A, Yuksel I, Alomari O, Atalar B, Gorken IB.

North Clin Istanb. 2024 Aug 1;11(4):302-308. doi: 10.14744/nci.2023.93196. eCollection 2024.

PMID: 39165702 Free PMC article.

 

71. Understanding national Societies' needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committee.

Atalar B, Mastroleo F, Zaffaroni M, Cremades V, Doolan P, Rønde HS, Clark CH, van der Heide UA, Boldrini L, Eriksen JG, Forde E, Kirby AM, Guckenberger M, Garibaldi C, Jereczek-Fossa BA.

Radiother Oncol. 2025 Sep;210:111006. doi: 10.1016/j.radonc.2025.111006. Epub 2025 Jun 28.

PMID: 40588037

 

72. Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey.

Sayan M, Eren MF, Kilic SS, Kotek A, Kaplan SO, Duran O, Cukurcayır F, Babalıoglu I, Or OD, Ozturk GA, Eroglu C, Teke F, Kurtul N, Kutuk T, Bicakci BC, Senyurek S, Aktan M, Mamidanna S, Ohri N, Haffty B, Atalar B.

BMC Cancer. 2022 May 12;22(1):532. doi: 10.1186/s12885-022-09558-5.

PMID: 35550042 Free PMC article.

 

73. Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study.

Sun XS, Le Guevelou J, Jacquemin J, Drouet Y, Sio TS, Bar-Sela G, Carrie C, Faivre JC, Khalifa J, Demiroz C, Qiu H, Schick U, Atalar B, Fakhry N, Mengue L, Pan J, Servagi-Vernat S, Thariat J.

Cancer Radiother. 2022 Sep;26(5):717-723. doi: 10.1016/j.canrad.2022.01.003. Epub 2022 Jun 14.

PMID: 35715353

 

74. A new perspective on the future of Turkish Society for Radiation Oncology: Young Radiation Oncologists Group (TROD/GROG 001).

Kaplan SO, Atalar B, Akboru MH, Tilki B, Kanat S, Yucel SB, Tepetam H, Ozyigit G.

Rep Pract Oncol Radiother. 2023 Apr 6;28(1):88-92. doi: 10.5603/RPOR.a2023.0004. eCollection 2023.

PMID: 37122905 Free PMC article. Review.

 

75. Biomechanical comparison of bone recycling methods in an ovine cortical bone model.

Aycan OE, Doğan B, Alpan B, Polat B, Atalar B, Erol K, Özger H.

Eur J Orthop Surg Traumatol. 2026 Jan 13;36(1):76. doi: 10.1007/s00590-025-04638-1.

PMID: 41528542

 

76. Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability.

Turner BE, Prabhu RS, Burri SH, Brown PD, Pollom EL, Milano MT, Weiss SE, Iv M, Fischbein N, Soliman H, Lo SS, Chao ST, Cox BW, Murphy JD, Li G, Gephart MH, Nagpal S, Atalar B, Azoulay M, Thomas R, Tillman G, Durkee BY, Shah JL, Soltys SG.

Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):579-586. doi: 10.1016/j.ijrobp.2019.10.002. Epub 2019 Oct 10.

PMID: 31605786 Free PMC article.

 

77. New horizons from novel therapies in malignant pleural mesothelioma.

Sayan M, Mamidanna S, Fuat Eren M, Daliparty V, Zoto Mustafayev T, Nelson C, Ohri N, Jabbour SK, Guven Mert A, Atalar B.

Adv Respir Med. 2020;88(4):343-351. doi: 10.5603/ARM.a2020.0103.

PMID: 32869268 Free PMC article. Review.

 

78. The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.

Dinçbaş FO, Oksüz DC, Atalar B, Altug T, Ilvan S, Gedik N, Ozel S, Koca S.

Med Oncol. 2009 Dec;26(4):402-8. doi: 10.1007/s12032-008-9136-1. Epub 2008 Nov 30.

PMID: 19043677

 

79. Radiation therapy for prostate cancer in Syrian refugees: facing the need for change.

Eren MF, Kilic SS, Eren AA, Kaplan SO, Teke F, Kutuk T, Bicakci BC, Hathout L, Moningi S, Orio P, Atalar B, Sayan M.

Front Public Health. 2023 May 31;11:1172864. doi: 10.3389/fpubh.2023.1172864. eCollection 2023.

PMID: 37325331 Free PMC article.

 

80. Epidural metastasis of Ewing's sarcoma: a rare localisation.

Dincbas FO, Oksuz DC, Atalar B, Dervisoğlu S, Kocer N, Mandel NM, Koca S.

J BUON. 2005 Apr-Jun;10(2):281-4.

PMID: 17343344

 

81. Unusual metastasis of renal cell carcinoma to the nasal cavity.

Dinçbas FO, Atalar B, Oksüz DC, Aker FV, Koca S.

J BUON. 2004 Apr-Jun;9(2):201-4.

PMID: 17415816

 

82. An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework.

Vandemaele M, Leech M, Aznar M, Blanchard P, Borr S JM, Lievens Y, Aggarwal A; ESTRO Value-Based Radiation Oncology collaborators.

Lancet Oncol. 2026 Mar;27(3):e160-e169. doi: 10.1016/S1470-2045(25)00732-6.

PMID: 41785906 Review.